Search Results - "O’Yang, Counde"
-
1
RO1138452 and RO3244794: characterization of structurally distinct, potent and selective IP (prostacyclin) receptor antagonists
Published in British journal of pharmacology (01-02-2006)“…Prostacyclin (PGI2) possesses various physiological functions, including modulation of nociception, inflammation and cardiovascular activity. Elucidation of…”
Get full text
Journal Article -
2
An allosteric PRC2 inhibitor targeting the H3K27me3 binding pocket of EED
Published in Nature chemical biology (01-04-2017)“…H3K27me3 binding to the EED pocket of the Polycomb repressive complex 2 (PRC2) is required to activate PRC2. An allosteric small-molecule inhibitor of PRC2 was…”
Get full text
Journal Article -
3
Convenient Method for the 3-Functionalization of Isoindazoles
Published in Synthetic communications (01-01-2006)“…The C-3 position of isoindazoles is readily functionalized by metalation with lithium diisopropylamide followed by reaction with a variety of electrophiles…”
Get full text
Journal Article -
4
Discovery of Small-Molecule Antagonists of the H3K9me3 Binding to UHRF1 Tandem Tudor Domain
Published in SLAS discovery (01-10-2018)“…Ubiquitin-like with PHD and RING finger domains 1 (UHRF1) is a multidomain protein that plays a critical role in maintaining DNA methylation patterns through…”
Get more information
Journal Article -
5
Synthesis and Biological Evaluation of Ketorolac Analogs
Published in Heterocycles (2002)Get full text
Journal Article -
6
Synthesis of 10,10-difluorothromboxane A2, a potent and chemically stable thromboxane agonist
Published in Journal of the American Chemical Society (01-06-1989)Get full text
Journal Article -
7
Discovery of First-in-Class, Potent, and Orally Bioavailable Embryonic Ectoderm Development (EED) Inhibitor with Robust Anticancer Efficacy
Published in Journal of medicinal chemistry (23-03-2017)“…Overexpression and somatic heterozygous mutations of EZH2, the catalytic subunit of polycomb repressive complex 2 (PRC2), are associated with several tumor…”
Get full text
Journal Article -
8
Discovery of the Clinical Candidate MAK683: An EED-Directed, Allosteric, and Selective PRC2 Inhibitor for the Treatment of Advanced Malignancies
Published in Journal of medicinal chemistry (14-04-2022)“…Polycomb Repressive Complex 2 (PRC2) plays an important role in transcriptional regulation during animal development and in cell differentiation, and…”
Get full text
Journal Article -
9
Preclinical pharmacokinetics and metabolism of MAK683, a clinical stage selective oral embryonic ectoderm development (EED) inhibitor for cancer treatment
Published in Xenobiotica (02-01-2022)“…MAK683 (N-((5-fluoro-2,3-dihydrobenzofuran-4-yl)methyl)-8-(2-methylpyridin-3-yl)-[1,2,4]triazolo[4,3-c]pyrimidin-5-amine) is a potent and orally bioavailable…”
Get full text
Journal Article -
10
Quantitative Profiling of Combinational K27/K36 Modifications on Histone H3 Variants in Mouse Organs
Published in Journal of proteome research (04-03-2016)“…The coexisting post-translational modifications (PTMs) on histone H3 N-terminal tails were known to crosstalk between each other, indicating their…”
Get full text
Journal Article -
11
Absolute Quantification of Histone PTM Marks by MRM-Based LC-MS/MS
Published in Analytical chemistry (Washington) (07-10-2014)“…The N-terminal tails of core histones harbor the sites of numerous post-translational modifications (PTMs) with important roles in the regulation of chromatin…”
Get full text
Journal Article -
12
Characterization of the analgesic and anti-inflammatory activities of ketorolac and its enantiomers in the rat
Published in The Journal of pharmacology and experimental therapeutics (01-03-1999)“…The marked analgesic efficacy of ketorolac in humans, relative to other nonsteroidal anti-inflammatory drugs (NSAIDs), has lead to speculation as to whether…”
Get more information
Journal Article -
13
Abstract 2461: Discovery of an orally available and liver-targeted ALPK1 agonist for cancer immunotherapy
Published in Cancer research (Chicago, Ill.) (22-03-2024)“…Boosting anti-tumor immune responses can be achieved by activating the innate immune system. Despite the ongoing development of numerous STING and TLR agonists…”
Get full text
Journal Article -
14
Abstract LB-288: An allosteric PRC2 inhibitor targeting the H3K27me3 binding pocket of EED
Published in Cancer research (Chicago, Ill.) (01-07-2017)“…Polycomb repressive complex 2 (PRC2) consists of three core subunits, EZH2, EED and SUZ12 and plays pivotal roles in transcriptional regulation through its…”
Get full text
Journal Article -
15
Stability of prostacyclin analogues: an unusual lack of reactivity in acid-catalyzed alkene hydration
Published in Pharmaceutical research (01-04-1988)“…Prostacyclin analogue 5 undergoes specific acid-catalyzed hydration (kH+ = 1.9 x 10(-7)M-1 sec-1 at 25 degrees C) and a pH-independent oxidation reaction (k0 =…”
Get full text
Journal Article